The c-Myb protein binds to DNA, can regulate transcription, and is required for normal hematopoiesis in vertebrates. Either amino-or carboxy-terminal truncation of this protein is required for ecient oncogenic activation. Previous studies have shown that the carboxyl terminus of c-Myb that is deleted in v-Myb contains negative regulatory domains. We now demonstrate that speci®c mutations within this carboxyl terminus result in greater transcriptional activation than truncation of the entire carboxyl terminus. Furthermore, this increased transcriptional activation depends upon the presence of the highly conserved Myb DNA-binding domain and is also dependent upon the nature of the Myb-binding sites within the target promoter. In a similar fashion, an activating mutation within the heptad leucine repeat region of c-Myb that is also present in v-Myb functions only in conjunction with the Myb DNA-binding domain and with particular Myb-binding sites. These results suggest a model in which multiple domains of the c-Myb protein are highly interdependent for transcriptional regulation. These interactions are promoter-speci®c and are not well modeled by heterologous fusion proteins.
Introduction
The c-myb gene plays a critical role in the development of a normal hematopoietic system in vertebrates (Mucenski et al., 1991) . The v-myb oncogenes of both AMV and the E26 acute leukemia viruses both encode internal portions of the c-Myb protein that are truncated at both their amino and carboxyl termini (reviewed in . Both c-Myb and v-Myb can function as DNA-binding transcription factors (reviewed in Ness, 1996) . The c-Myb proteins are highly conserved among vertebrates and contain an amino-terminal DNA-binding domain comprised of three imperfect ®fty-two amino acid Myb repeats, a central transcriptional activation domain adjacent to a heptad leucine repeat, and a carboxy-terminal negative regulatory region (Klempnauer and Sippel, 1987; Sakura et al., 1989) (Figure 1 ). Fusion proteins in which the DNA-binding domain of v-Myb or c-Myb was replaced by that of the yeast transcription factor GAL4, were used to map a central transcriptional activation domain (Kalkbrenner et al., 1990; Weston and Bishop, 1989) . However, this activation domain is not sucient for transcriptional activation in the context of the native v-Myb protein .
A c-Myb negative regulatory region was identi®ed by demonstrating that truncation of the carboxyl terminus can increase transcriptional activation, both in GAL4-c-Myb fusions and in the native protein (Hu et al., 1991; Kalkbrenner et al., 1990; Sakura et al., 1989) . This negative regulatory activity was mapped to two non-contiguous regions of chicken c-Myb (PS and BN) using a series of small carboxy-terminal deletions in a GAL4-c-Myb fusion protein (Dubendor et al., 1992) . Interestingly, a region of the carboxyl terminus which lies between these two negative regulatory domains has been highly conserved among the c-Myb proteins of vertebrates, the related A-Myb and B-Myb proteins of vertebrates, and the Myb proteins of sea urchins and Drosophila, but this region has no known function . When full-length c-Myb and carboxy-terminal truncations were assayed for transcriptional activation in budding yeast, no negative regulation was observed (Chen and Lipsick, 1993; Seneca et al., 1993) . These results imply that additional animal cell-speci®c proteins may be required for negative regulation by the carboxyl terminus.
Recent work has characterized more precisely the Myb sequences that are associated with both positive and negative control of transcriptional activation function. Amino-terminal truncation into the DNAbinding domain reduces the anity of c-Myb for DNA both in vitro and in vivo, possibly correlating with the high transformation activity of such mutants (Dini and Lipsick, 1993) . In contrast, a negatively charged region amino-terminal to the Myb repeats appears to inhibit both DNA-binding and transcriptional activation. In addition, oncogenic amino terminal truncations permit transcriptional inhibition by cyclin D in a CDKindependent fashion . A heptad leucine repeat region that contains a putative`leucine zipper' has been proposed to function in negative regulation, possibly by promoting c-Myb dimer formation and/or binding to other proteins (KaneiIshii et al., 1992; Nomura et al., 1993; Tavner et al., 1998) . However, the region containing this heptad leucine repeat, but not the leucines themselves, was shown to be required for both transcriptional activation and transformation by v-Myb (Fu and Lipsick, 1996) . Transcriptional activation therefore appears not to be encoded merely within a single central domain of v-Myb, but instead lies within several subdomains throughout the protein (Chen et al., 1995; Fu and Lipsick, 1996) . An additional transcriptional activation domain has been mapped within the carboxyl terminus when c-Myb is assayed in budding yeast (Seneca et al., 1993) .
DNA binding appears to be the only function located within a contiguous domain, but this also may be negatively regulated by carboxy-terminal sequences Tanaka et al., 1997) . Studies using phage display or yeast two-hybrid assays have also suggested that the DNA-binding domain and the carboxyl terminus of c-Myb may physically interact with one another (Dash et al., 1996; Keiwitz and Wolfes, 1997) . A protein called p100 has been proposed to competitively inhibit this interaction, thereby regulating c-Myb function (Dash et al., 1996) . p100 was identi®ed because of a sequence similarity to the`EVES' motif within the carboxyl terminus of c-Myb which was required for interaction with the DNA-binding domain in yeast two-hybrid assays. Transient infection of a p100 expression vector inhibited transcriptional activation by c-Myb. Interestingly, the same protein was previously identi®ed as a co-activator for the EBNA 2 protein of the EpsteinBarr virus (Tong et al., 1995) .
Much of this work paints an increasingly complex picture of the domain organization of c-Myb. In order to examine the function and cooperation of c-Myb domains, we have continued our investigation of the carboxy-terminal region by now using deletion mutants in the context of the Myb DNA-binding domain. In addition, we have constructed and tested a new series of linker insertion mutants within the central activation domain, heptad leucine repeat region and the negative regulatory domains of the carboxyl terminus of c-Myb including the`EVES' sequence. Our analysis implies that the regulatory function of the carboxyl terminus is highly dependent upon both the Myb DNA-binding domain and the presence of particular Myb-binding sites within the target promoter. These results are reminiscent of recent models of glucocorticoid receptor function in which the DNA itself has been proposed to be an allosteric eector of the protein (Lefstin and Yamamoto, 1998) .
Results

The carboxyl-terminus of c-Myb is required for maximal transcriptional activation
In order to investigate the role of the central acidic and heptad leucine repeat regions in transcriptional activation by c-Myb, we generated two linker insertion mutations in c-Myb similar to those originally constructed in v-Myb (Lane et al., 1990) . The 859 mutation inserted two additional amino acids (Gly ± Pro) within the central v-Myb transcriptional activation domain (corresponding to an insertion after residue 304 in chicken c-Myb, 304GP) and abolished its activity. In contrast, the 1114 mutation which Figure 1 . The arrowheads represent the sites of two or three amino acid in-frame insertions in c-Myb that are presented in more detail in Figure 3 . Each c-Myb mutant was assayed at least three times. CCC is the full-length chicken c-Myb protein. Data are presented relative to CCd that was arbitrarily assigned a value of 1.00. Bars indicate mean values and average deviation of the mean inserted three amino acids (Gly ± Pro ± Asn) within the heptad leucine repeat of v-Myb (corresponding to an insertion after residue 389 in chicken c-Myb, 389GPN) increased the transcriptional activation activity of that protein. In addition, we constructed a double linker insertion in c-Myb containing both the 304GP and 389GPN mutations.
In the context of full-length c-Myb, the 304GP mutation decreased transcriptional activation from a reporter containing ®ve strong Myb-binding sites from the mim-1 promoter and a simple TATA box by approximately 50% (Figure 2 ). This result implies that the central acidic domain that is conserved in all c-Myb and A-Myb proteins of vertebrates, but not in B-Myb proteins of vertebrates or Myb proteins of invertebrates, is required for full transcriptional activation by c-Myb. In contrast, the 389GPN mutation greatly increased transcriptional activation of full-length c-Myb by approximately sixfold (Figure 2 ). This was significantly greater than the twofold increase caused by deletion of the entire carboxyl terminus of c-Myb that is missing in v-Myb (CCd). The presence of both the 304GP and the 389GPN mutations in full-length c-Myb resulted in transcriptional activation at levels similar to that of CCd. Similar levels of all of the dierent Myb proteins were detected by immunoblotting (data not shown). These results imply that alteration of the heptad leucine repeat region can reveal a latent transcriptional activation that requires the presence of both the central acidic domain and the intact carboxyl terminus of cMyb for maximal activity. However, the central acidic domain is not absolutely required for transcriptional activation in the presence of the 389GPN mutation in the heptad leucine repeat region as shown by activity of the double mutant 304GP/389GPN.
To further investigate the function of the carboxyl terminus of c-Myb in transcriptional activation, we also generated a new series of linker insertion mutations at c-Myb amino acids 412GPN, I460MGP, 493GPT, 506WAQ and 532WAQ (Figures 2 and 3 ). Of the ®ve additional linker insertions in the new series, only the one designated as 532WAQ showed higher activity than c-Myb itself ( Figure 2 ). However, it was only as active as the carboxy-terminally truncated control, CCd, and did not exhibit the much higher activity seen with mutant 389GPN. Linker insertion 532WAQ is of particular interest because it occurs within the BN negative regulatory domain adjacent to a MAPK kinase phosphorylation site (Aziz et al., 1993 (Aziz et al., , 1995 . In addition this mutation disrupts the`EVES' motif that has been reported to interact with the Myb DNA-binding domain in yeast two-hybrid assays (Dash et al., 1996) . Our results are consistent with a model in which this region of c-Myb can inhibit transcriptional activation by c-Myb. However, these data also imply that p100 alone is unlikely to be responsible for negatively regulating the full activity of c-Myb that can be revealed by alterations in the heptad leucine repeat region such as the 389GPN mutation.
Deletion of two negative regulatory domains in the carboxyl terminus activates c-Myb more than simple truncation
We previously used deletion mutations in a GAL4-cMyb fusion protein (GAL4-CC) to map negative regulation of transcriptional activation via a reporter gene containing ®ve GAL4-binding sites (Dubendor et al., 1992) . A GAL4 fusion containing the entire carboxyl terminus of c-Myb was transcriptionally inactive, whereas a deletion similar to that found in v-Myb was quite active. We then attempted to map the negative regulatory domain and found that a series of adjacent, single small deletions within the carboxyl Figure 3 Alignment and location of mutations in the carboxyl terminus of c-Myb. Myb protein sequences were aligned using the CLUSTALW implementation of the Parsimony After Progressive Alignment (PAPA) method (Feng and Doolittle, 1990; Thompson et al., 1994) with some additional adjustments based on blocks identi®ed with the MACAW local alignment program (Schuler et al., 1991) . Shading was then performed using the BOXSHADE program. Black shading indicates identical residues at a given position; gray shading indicates similarity. Hu=human; Ch=chicken; Xe=Xenopus; Urchin=sea urchin; Dros=Drosophila. Residues similar to those in alternatively spliced Exon 9A of c-Myb are not shown. AMV=carboxy-terminal truncation of v-Myb of AMV; the a and d positions in a predicted helical wheel are indicated above the alignment of the central activation domain sequences; hexagons=the leucines of two heptad leucine repeats also referred to as the`leucine zipper'; asterisks=highly conserved putative phosphorylation sites for proline-directed kinases; PS and BN=deletions in c-Myb that together activate transcription; EVES=sequence that mediates interaction with the DNAbinding domain in yeast two-hybrid assays and that also contains a serine that is phosphorylated in c-Myb in vivo and by MAPK in vitro; arrows indicate positions of residues introduced by the linker insertion mutants described in this paper. All sequences were obtained from the Genbank resource at NCBI terminus showed little or no activity compared with the highly active carboxy-terminal truncation, GAL4-Cd. However, the PS/BN double deletion (aa 425 ± 464 and 499 ± 558) within the carboxyl terminus showed approximately 60 ± 70% of the activity of the carboxy-terminally truncated fusion protein, confirming the negative regulatory activity of these two domains. We obtained similar results with LexA-cMyb fusion proteins, and in this case we also showed that the carboxyl terminus of c-Myb inhibited transcriptional activation, but not nuclear transport or DNA binding.
Studies of v-Myb showed that mutations within the DNA-binding domain may aect transcriptional activation without diminishing DNA binding (Grasser et al., 1992; Lane et al., 1990) . Furthermore, mapping of transcriptional activation domains of native v-Myb gave quite dierent results than studies of GAL4-vMyb fusion proteins (Chen et al., 1995; Fu and Lipsick, 1996; Ibanez and Lipsick, 1990) . Therefore, we wished to determine the eect of deleting the two previously de®ned carboxy-terminal negative regulatory domains of c-Myb in the presence of the highly conserved Myb DNA-binding domain.
The transcriptional activation of full-length c-Myb (CCC), a complete carboxy-terminal deletion similar to that of v-Myb (CCd), a variant of c-Myb containing two smaller deletions of the negative regulatory domains (CCC PS/BN), and the linker insertion within the heptad leucine repeat (389GPN) were compared ( Figure 4) . We initially used the same reporter gene described above that contains ®ve tandem copies of the strongest (type A) Myb-binding site from the mim-1 promoter (Ness et al., 1989) , a simple TATA box from the adenovirus E1b gene (Lillie and Green, 1989 ) and the luciferase coding region (EW5-LUC). The PS/BN double deletion mutant of cMyb was remarkable in that it activated transcription to a much greater degree than a complete deletion of the carboxyl terminus. This heightened activity of the CCC PS/BN mutant was similar to that of the 389GPN mutant that altered the heptad leucine repeat region. This heightened activity was not observed with deletion of either the PS or BN region alone (Figure 4 and data not shown). These results suggest that both of these mutant proteins may be disrupting a similar intrinsic inhibitory conformation of full-length c-Myb.
Transcriptional regulation by the carboxyl terminus of c-Myb is dependent upon the DNA to which the protein is bound
We had previously noted that negative regulation by the carboxyl terminus of c-Myb seemed to vary depending upon the promoter being tested. In particular, a promoter containing nine Myb-binding sites from chicken genomic DNA (KHK) placed upstream of the same TATA box was minimally activated by full-length c-Myb, but was markedly activated by v-Myb or a similar carboxy-terminal truncation of c-Myb (Dubendor et al., 1992) . In contrast, a promoter containing ®ve copies of the strong Myb-binding site from the mim-1 promoter upstream of the same TATA box could be activated by both v-Myb and c-Myb. We therefore wished to test whether the`superactivation' caused by the 389GPN and CCC PS/BN mutations was dependent upon the promoter (Figure 4) . Consistent with our previous report using CAT reporter genes, full-length CCC barely activated the KHK ± LUC reporter gene whereas the truncated CCd protein activated the same reporter reasonably well. The CCC PS/BN double deletion within the carboxyl terminus was more active on KHK ± LUC than a simple truncation, similar to results with the EW5-reporter gene. However, the 389GPN linker insertion within the heptad leucine repeat did not activate the KHK ± LUC reporter as well as CCd, whereas 389GPN was much more active than CCd on the EW5 ± LUC reporter. Similar levels of each Myb protein were produced with either reporter indicating that dierential protein stability cannot account for the observed dierences in transcriptional activation ( Figure 5 ). These data demonstrate that transcriptional regulation by the carboxyl terminus of c-Myb is quite dependent upon the DNA to which the protein is bound.
Transcription regulation by the carboxyl terminus of c-Myb depends speci®cally upon the Myb DNA-binding domain
We had previously shown that a speci®c double deletion within the carboxyl terminus of c-Myb (PS/ BN) could activate a GAL4-c-Myb fusion protein approximately 60 ± 70% as well as a simple carboxyterminal truncation (Dubendor et al., 1992) . However, in the context of the full-length protein this double deletion was much more active than a simple carboxy-terminal truncation (Figure 4) . These results suggested that the presence of the Myb DNA-binding domain was required for this increased activation. We therefore wished to determine whether the increased transcriptional activation by the 389GPN linker insertion mutant within the heptad leucine repeat region also required the presence of the Myb DNAbinding domain. For this purpose, a series of GAL4-Myb fusion proteins were produced and tested for their ability to activate a reporter gene containing GAL4-binding sites upstream of the same minimal TATA box ( Figure 6 ). As previously reported, a fusion protein containing the full-length carboxyl terminus of c-Myb (GAL4-CC) was inactive, whereas a carboxy-terminal truncation similar to that of v-Myb (GAL4-Cd) was quite active. A fusion protein containing the PS/BN double deletion within the carboxyl terminus (GAL4-CC PS/BN) was almost as active as a complete truncation. However, the linker insertion mutant within the heptad leucine repeat region was completely inactive without the Myb DNA-binding domain (GAL4-CC 389GPN). Similar levels of each GAL4 Myb protein were produced, indicating that dierential protein stability cannot account for the observed dierences in transcriptional activation (Figure 7) . In fact, the most active protein (GAL4-CCd) was actually the least abundant. These results imply that relief of negative regulation by disruption of the heptad leucine Figure 5 Dierential activation of promoters by C-terminal mutants of c-Myb does not depend upon dierential protein production. Extracts of the same cells used for luciferase assays with the KHK (K) or the EW5 (E) promoters in Figure 4 were resolved by SDS ± PAGE. The Myb proteins were then detected by immunoblotting using anti-Myb monoclonal antibodies. The relative mobility of molecular weight standards is indicated on the right Figure 6 Lack of activation by GAL4-c-Myb fusion protein with a heptad leucine repeat disruption. Four dierent GAL4-c-Myb fusion proteins were assayed for transcriptional activation using a reporter in which ®ve GAL4-binding sites were placed upstream of the same simple TATA box and a luciferase cDNA. Each activator was assayed at least three times. Data are presented relative to GAL4-Cd which was arbitrarily assigned a value of 1.00. Bars indicate mean values and average deviation from the mean repeat region requires the speci®c presence of the Myb DNA-binding domain, as does`superactivation' the double deletion within the carboxyl terminal negative regulatory domain.
Discussion
A variety of experiments have suggested that eukaryotic transcription factors are composed of separable DNA-binding and activation domains (Ptashne, 1988 ). This conclusion is based largely upon the fusion of functional domains of heterologous proteins, often from dierent species. In this study we have examined the role of dierent regions of the c-Myb protein in transcriptional regulation. Initial studies with deletion mutants demonstrated that c-Myb had three functional domains, an amino-terminal DNA binding domain, a central transcriptional activation domain, and a carboxy-terminal negative regulatory domain (Sakura et al., 1989) . Fusions of v-Myb and c-Myb with the DNA-binding domains of GAL4 and LexA were also used to de®ne a central transcriptional activation domain (Kalkbrenner et al., 1990; Weston and Bishop, 1989) . However, more detailed studies have shown that in the case of v-Myb, the activation domain identi®ed by GAL4 fusions is not sucient for transcriptional activation or oncogenic transformation in the context of the native protein (Chen et al., 1995; Fu and Lipsick, 1996; Ibanez and Lipsick, 1990) . Furthermore, mutants within the DNA-binding domain of v-Myb have been identi®ed that still bind DNA, but no longer can activate transcription (Grasser et al., 1992; Lane et al., 1990) . These results have suggested that the interplay among the dierent domains of v-Myb and c-Myb is more complicated than suggested by the standard independent-domain model of transcriptional activators.
The failure of the disruption of the heptad leucine repeat to activate transcription in GAL4-fusion proteins suggest that rather than being a negative regulator itself, mutations in this region of the protein may regulate the conformation and interaction of other domains of the c-Myb protein. In this regard, we have also observed that the presence of the alternatively spliced exon 9A sequences that also interrupt this heptad leucine repeat region can cause increased transcriptional activation by c-Myb proteins (Woo et al., 1998) .
Inspection of the sequence of the central transcriptional activation domain that is conserved among all known c-Myb and A-Myb proteins reveals the presence of another hydrophobic heptad repeat with predicted alpha ± helical content. In fact, this region scores much higher using the COILS prediction program than that in the more carboxy-terminal heptad leucine repeat (Lupas et al., 1991) . Furthermore, a Gly ± Pro insertion in this region greatly diminishes transcriptional activation by both v-Myb and c-Myb. These results suggest that the predicted amphipathic helix in this region is likely to be important for the function of the central activation domain. In this region of c-Myb and A-Myb, the predicted a positions of the heptad helical wheel are occupied by Ile, Leu, and Leu, and the predicted d positions are occupied by Lys, Leu, and Thr or Ala (Figure 3) . This observation suggests a model in which the previously described heptad leucine repeat region near the carboxyl-terminus of v-Myb interacts with a similar motif within the central transcriptional activation domain (Figure 8 ). In support of such a model, we note that both of these regions are conserved in all known c-Myb and A-Myb proteins, but not in the B-Myb or invertebrate Myb proteins. In addition, we have previously reported that the same 1114 linker insertion (389GPN in c-Myb) can increase transcriptional activation by the v-Myb protein itself (Lane et al., 1990) . The central activation domains of c-Myb and A-Myb have been shown to bind to the transcriptional coactivator CBP (Dai et al., 1996; Facchinetti et al., 1997; Oelgeschlager et al., 1996) . Therefore, an interesting possibility is that the previously described heptad leucine repeat of c-Myb may limit the access of CBP to the central activation domain.
The`superactivation' by mutants of c-Myb with an insertion in the heptad leucine repeat or with two small deletions within the carboxyl terminus also suggests that an additional transcriptional activation domain may be present within the carboxyl terminus of c-Myb. Consistent with this hypothesis, a linker insertion mutation within the central activation domain (304GP) greatly reduces overall transcriptional activation by c-Myb, but does not abolish the ability of the linker insertion mutation within the heptad leucine repeat to increase the residual transcriptional activation A candidate for such a`cryptic' transcriptional activation domain is the very highly conserved, threonine/proline-rich sequence within the carboxyl terminus of c-Myb, AMyb, B-Myb, sea urchin Myb, and Drosophila Myb that as yet has not been assigned any function. This region has been reported to augment but not be sucient for transcriptional activation by B-Myb (Nakagoshi et al., 1993) .
In this paper we have found that either disruption of the heptad leucine repeat or the introduction of two small deletions within the carboxyl terminus of c-Myb can increase transcriptional activation signi®cantly more than a simple carboxyl-terminal truncation.
Presumably these mutations mimic physiologic protein-protein interactions or post-translational modifications that serve a similar function in vivo. Interestingly, both the Myb DNA-binding domain and speci®c promoter DNAs are required for this`superactivation'. In this regard, the regulation of c-Myb appears to be similar to that of the glucocorticoid receptor in which DNA itself can be viewed as an allosteric eector of transcriptional activation (Lefstin and Yamamoto, 1998) .
Materials and methods
Plasmid constructions
DNA restriction and modifying enzymes were purchased from New England Biolabs (Beverly, MA, USA). Recombinant DNA manipulations were carried out using standard techniques (Ausubel et al., 1989) . Retroviral constructs that express c-Myb and c-Myb truncations have been described (Dini and Lipsick, 1993; Fu and Lipsick, 1997; Grasser et al., 1991) . Single and double truncations of c-Myb are named accordingly to the sequences present (C) or deleted (d) in a fashion similar to v-Myb. Thus, the c-Myb proteins deleted of amino-terminal, carboxy-terminal, or both sequences missing in v-Myb are referred to as dCC, CCd or dCd, respectively.
Deletions within the carboxyl terminus of c-Myb were constructed by blunt-end ligation of the appropriately In (c) , the`open' superactivated state is produced either by disruption of the HLR-TA interaction (linker insertion 389GPN in the HLR), or by disruption of the CTA/NR-TA interaction by speci®c deletions in the carboxyl terminus (dPS/BN). In this case the speci®c interaction of the Myb DNA-binding repeats near the amino terminus (N) with a sequence of sequences in the carboxyl terminus (C) is required to maintain the highly active conformation. Thus, superactivation is not possible with the GAL4-c-Myb fusion proteins restricted and Klenow-treated DNA where such treatment would give in-frame deletions, or by the use of singlestranded DNA adaptors as described previously (Dubendor et al., 1992) . The resulting deletions within the carboxyl terminus were transferred from the pSG424 plasmid expressing them as GAL4 fusion proteins to the retroviral construct that expresses them as native c-Myb derivatives through a pSP73 intermediate containing the chicken c-myb gene (pSP73CCC; Dini and Lipsick, 1993) . Brie¯y, XmaI ± BamHI fragments from pSG424 derivatives carrying each carboxy-terminal deletion were used to replace the wild type fragment of pSP73CCC. The entire coding sequence for each c-Myb mutant was then transferred to the retroviral vector on a ClaI fragment. Carboxy-terminal deletions are named according to the restriction sites used to make the deletion (Dubendor et al., 1992) . All of the mutant proteins migrated with the expected relative mobilities on sodium dodecyl sulfate ± polyacrylamide gel electrophoresis (SDS ± PAGE).
The v-Myb 1114 linker insertion (389GPN in c-Myb) was transferred from v-Myb into c-Myb on a SalI ± MscI fragment, and from c-Myb into GAL4-c-Myb using the XmaI ± BamHI fragment described above. The 304GP and I460MGP mutations were made by ligating a kanamycin selection cassette¯anked by ApaI linkers into plasmid DNA that had been linearized at HincII and SspI sites, respectively (Lane et al., 1990) . Construction of additional linker insertion mutations was by a modi®cation of this method in order to target the insertions to blunt-ended HinfI sites within a speci®c region of the plasmid DNA (Dubendor, 1997) . All mutant proteins encoded by these linker insertion mutants exhibited SDS ± PAGE mobilities indistinguishable from that of wild-type c-Myb.
Reporter plasmids bearing ®ve type A Myb-binding sites derived from the mim-1 promoter sequence (EW5), nine Myb-binding sites from chicken genomic DNA (KHK), or ®ve GAL4-binding sites were constructed by cloning the appropriate DNA fragments into polyA-E1b-Luc or E1b-CAT, which contain a synthetic adenovirus E1b TATA sequence driving luciferase or CAT gene expression, respectively (Fu and Lipsick, 1996; Lillie and Green, 1989) .
Cells and media
Quail QT6 ®broblasts were grown in Dulbecco's modi®ed essential medium (DMEM) supplemented with 5% fetal calf serum, 4.5 g of glucose per liter, nonessential amino acids, Lglutamine, sodium pyruvate, 100 ug of streptomycin per ml, and 100 U of penicillin per ml in a humidi®ed 10% CO 2 /90% air incubator at 378C.
DNA transfections, immunoblotting and assays for b-galactosidase, luciferase and CAT activity Transient transfections into QT6 quail ®broblasts were performed using a modi®cation of the calcium phosphate procedure of Chen and Okayama as described previously (Chen and Okayama, 1987; Ibanez and Lipsick, 1990) . Transfections included 2 ± 5 mg of activator plasmid, 1 mg reporter DNA, 0.5 mg of a plasmid expressing b-galactosidase (b-gal) from the CMV promoter as an internal control for transfection eciency, and sucient yeast tRNA to bring the total amount of nucleic acids to 10 mg per 10 cm diameter plate of cells.
Half of the cells from each transfection were solubilized by boiling for 4 min in SDS ± PAGE loading buer. Volumes of each sample normalized for b-gal activity were then subjected to SDS ± PAGE through 10% gels and the proteins transfected to nitrocellulose (BA85; Schleicher & Schuell, Keen, NH, USA). Transiently expressed Myb proteins were detected using monoclonal anti-Myb-2.2, 2.7 or 5E11 antibodies (Evan et al., 1984; Sleeman, 1993) . Blots were developed using rabbit anti-mouse immunoblobulin G conjugated to alkaline phosphatase (Promega, Madison, WI, USA) and BCIP/NBT.
Cell extracts were prepared from the other half of each transfection and b-gal activity and luciferase activities were determined as previously described (Ausubel et al., 1989; Sambrook et al., 1989) . The phase extraction method was employed to determine the CAT activity in normalized volumes of extract as previously described (Seed and Sheen, 1988) . Appropriate dilutions were assayed in those cases where the level of CAT activity indicated that substrate was limiting. A background value was obtained by extracting CAT assay mix to which no cell extract had been added. Activities shown in the ®gures have been corrected for background and represent the averages of at least three experiments.
